Authors:
Parsons, SK
Levine, KJ
Hoorntje, LE
Eichelberger, WJ
Mayer, DK
Guinan, EC
Citation: Sk. Parsons et al., Impact of pharmacy practices on the cost of colony-stimulating factor use in pediatric stem cell transplantation: An institution-based analysis, J PED H ONC, 23(1), 2001, pp. 19-24
Authors:
Parsons, SK
Mayer, DK
Alexander, SW
Xu, RH
Land, V
Laver, J
Citation: Sk. Parsons et al., Growth factor practice patterns among pediatric oncologists: Results of a 1998 Pediatric Oncology Group survey, J PED H ONC, 22(3), 2000, pp. 227-241
Authors:
Parsons, SK
Hoorntje, LE
Levine, KJ
Mayer, DK
Eichelberger, WJ
Guinan, EC
Citation: Sk. Parsons et al., Balancing efficacy with cost: antiemetic control in the pediatric stem cell transplant (SCT) population, BONE MAR TR, 25(5), 2000, pp. 553-557
Authors:
Parsons, SK
Gelber, S
Cole, BF
Ravindranath, Y
Ogden, A
Yeager, AM
Chang, M
Shuster, J
Weinstein, HJ
Gelber, RD
Citation: Sk. Parsons et al., Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821, J CL ONCOL, 17(7), 1999, pp. 2144-2152
Authors:
Parsons, SK
Barlow, SE
Levy, SL
Supran, SE
Kaplan, SH
Citation: Sk. Parsons et al., Health-related quality of life in pediatric bone marrow transplant survivors: According to whom?, INT J CANC, 1999, pp. 46-51